This article was the first to show that CB1R activation plays an important role in the pathogenesis of DR and that CB1R antagonists may be beneficial in reducing diabetes-induced oxidative/nitrative stress and vasculopathy. The gene discussed is CNR1; the disease is vascular disorder.